BackDeep Medicine Acquisition - Tradeable Rights - Oct 2026 Overview

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Assets

Deep Medicine Acquisition - Tradeable Rights - Oct 2026's total assets is $18M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$18.00M
↓ 26.10% YoYΔ $-6.36M vs prior year quarter

Peer trimmed avg / median

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Assets History

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 vs. peers: Total Assets Comparison

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) FAQ

The latest total assets for DMAQR is $18M as of June 2026. That compares with $24M in the prior-year period — down 26.1% year over year. Investors often review this figure alongside Deep Medicine Acquisition - Tradeable Rights - Oct 2026's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQR's total assets moved from $24M to $18M — a 26.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Tradeable Rights - Oct 2026's operating scale or balance-sheet position.

A total assets figure of $18M for DMAQR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAQR's total assets ($18M), review year-over-year change from $24M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.